Clinician Early Access Program

We invite clinicians early access to Predicine’s products and the opportunity to join a collaborative working group to bring rapid access to greater number of patients who might benefit from Predicine’s products.

Clinician access program

We invite clinicians and investigators early access to Predicine’s products and the opportunity to join a collaborative working group to:

  • Identify clinical needs
  • Participate in discussions on collaboration scope
  • Provide insights and input
  • Contribute to clinical utility studies & publications

Enrollment for early access collaborators start in Q2 2021

Early Access Program

How can we support you? If you are a healthcare professional seeking access to a Predicine product, or for further information on partnering with Predicine.

    Best description of current clinical liquid comprehensive molecular profiling (CGP) usage

    Predicine_MassimoCristofanilli

    “Liquid biopsy is the future of precision medicine. Our work with Predicine’s liquid biopsy platform is very encouraging for the field of liquid biopsy and supports its clinical application for patient care.”

    Massimo Cristofanilli, M.D.
    Professor of Northwestern University and President of International Society of Liquid Biopsy